205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
6.02%
Revenue growth similar to AMD's 6.62%. Walter Schloss would see if both companies share industry tailwinds.
7.03%
Gross profit growth at 75-90% of AMD's 9.21%. Bill Ackman would demand operational improvements to match competitor gains.
10.15%
EBIT growth below 50% of AMD's 27.27%. Michael Burry would suspect deeper competitive or cost structure issues.
10.59%
Operating income growth under 50% of AMD's 27.50%. Michael Burry would be concerned about deeper cost or sales issues.
2.86%
Net income growth under 50% of AMD's 43.21%. Michael Burry would suspect the firm is falling well behind a key competitor.
3.62%
EPS growth under 50% of AMD's 50.00%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
3.70%
Diluted EPS growth under 50% of AMD's 37.50%. Michael Burry would worry about an eroding competitive position or excessive dilution.
-0.61%
Share reduction while AMD is at 3.47%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-0.80%
Reduced diluted shares while AMD is at 10.39%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
-0.21%
Dividend reduction while AMD stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
64.21%
OCF growth 1.25-1.5x AMD's 47.67%. Bruce Berkowitz would see if superior pricing or efficient operations explain the gap.
70.86%
FCF growth above 1.5x AMD's 33.33%. David Dodd would verify if the firm’s strategic investments yield superior returns.
61.96%
Positive 10Y revenue/share CAGR while AMD is negative. John Neff might see a distinct advantage in product or market expansion over the competitor.
48.84%
5Y revenue/share CAGR above 1.5x AMD's 6.83%. David Dodd would look for consistent product or market expansions fueling outperformance.
31.55%
3Y revenue/share CAGR at 75-90% of AMD's 38.43%. Bill Ackman would expect new product strategies to close the gap.
375.35%
10Y OCF/share CAGR above 1.5x AMD's 89.23%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
205.86%
5Y OCF/share CAGR above 1.5x AMD's 9.19%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
135.70%
3Y OCF/share CAGR above 1.5x AMD's 42.38%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
222.83%
Net income/share CAGR above 1.5x AMD's 105.62% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
140.33%
5Y net income/share CAGR at 50-75% of AMD's 210.72%. Martin Whitman might see a shortfall in operational efficiency or brand power.
113.67%
3Y net income/share CAGR 75-90% of AMD's 147.59%. Bill Ackman might push for an operational plan to match or beat the competitor’s short-term growth.
43.90%
Positive growth while AMD is negative. John Neff might see a strong advantage in steadily compounding net worth over a decade.
8.47%
Below 50% of AMD's 72.94%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
10.29%
Below 50% of AMD's 562.95%. Michael Burry suspects a serious short-term disadvantage in building book value.
520.27%
Dividend/share CAGR of 520.27% while AMD is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
121.41%
Dividend/share CAGR of 121.41% while AMD is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
81.19%
3Y dividend/share CAGR of 81.19% while AMD is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
6.67%
AR growth is negative/stable vs. AMD's 51.49%, indicating tighter credit discipline. David Dodd confirms it doesn't hamper actual sales.
2.85%
Inventory growth well above AMD's 4.90%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
5.83%
Asset growth at 50-75% of AMD's 9.04%. Martin Whitman questions if the firm is lagging expansions or if the competitor invests more aggressively.
0.54%
Under 50% of AMD's 18.81%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
24.23%
Debt growth far above AMD's 0.36%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
-0.26%
Our R&D shrinks while AMD invests at 4.08%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
1.85%
SG&A declining or stable vs. AMD's 5.97%. David Dodd sees better overhead efficiency if it doesn't hamper revenue.